Larvol Delta - BMS986500-A-novel-molecular-glue-degrader-of-Cyclin-E1-with-firstinclass-potential-for-treating-CCNE1amplified-cancers-and-overcoming-CDK46-inhibitor-resistance-in-HR-breast-cancer

Sotyktu (deucravacitinib) - BMS

http://clinicaltrials.gov/ct2/show/NCT04036435

Sep 11, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next